4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-24-025690
Options or other derivatives
- Director acquired 4,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lindsay Mark F. Director | 2024-06-20 | Grant or award · Stock Option (Right to Buy) | +4,000 | $2.38 | $9,520 | 7,067 | D |
Loading xslF345X05/ownership.xml…